Day: July 24, 2021

New Saturn-1 data demonstrated a strong patient responder rate with 95% of Demodex blepharitis patients treated with TP-03 achieving ≤0.5 mites per lash and 93% improving by at least one collarette grade Further Saturn-1 safety analysis revealed that TP-03 had a favorable safety profile with no clinically significant effect on multiple measures Titan study reveals the high real-world prevalence of Demodex blepharitis, with collarettes present in 58% of U.S. patients visiting an eye doctor IRVINE, Calif., July 24, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced new data from its Saturn-1 Phase 2b/3...

MCCALL, Idaho, July 23, 2021 (GLOBE NEWSWIRE) — Today, Idaho First Bank (the ‘Bank’) and Peak Bancorp, Inc. (the ‘Corporation’) (OTCPINK: IDFB) announced they have consummated their share exchange whereby the Corporation, an Idaho corporation created by the Bank’s Board of Directors, became the Bank’s holding company.  Shareholders who owned stock in the Bank became shareholders of the Corporation, with the Corporation owning 100% of the Bank. The Bank’s shareholders approved the share exchange during their annual meeting on April 26, 2021, and recently received approval from the Federal Reserve Bank of San Francisco.  “We are excited to announce the completion of Idaho First Bank’s reorganization and the founding of Peak Bancorp, Inc.,” stated Todd Cooper, CEO of Idaho First Bank. “This new structure will allow us to further...